Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense
Year: 2003
Type: article
Study design: Observational Study
Source: Annals of the Rheumatic Diseases
Authors: R van Vollenhoven, A Harju, S Brannemark, L Klareskog
Institution: Karolinska University Hospital
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Reumatikerförbundet
OpenAlex ID: W2122265491
